INHIBITOREN DES HEPATITIS-C-VIRUS

Patent europeic · EP2049522 · Stritgà

Inscripziun en il register

Numer da publicaziun: EP2049522
Numer da la dumonda: EP07800058
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: Stritgà
Scrittira da patent: Concedì
Annunzià: 09-08-2007
Publitgà: 22-04-2009
Concedì: 14-05-2014
Stritgà: 31-08-2020
Motiv: Taxa annuala betg pajada
Classas IPC: C07D 401/14 (2006.01)
C07D 403/14 (2006.01)
A61P 31/12 (2006.01)
A61K 31/4025 (2006.01)
A61K 31/4178 (2006.01)
Prioritad: US 836996 P 11.08.2006
US 835462 08.08.2007
Dumonda PCT: PCT/US2007/075544 09.08.2007
Publicaziun PCT: WO2008/021927 21.02.2008
Lingua da l’annunzia: englais
Funtauna: Swissreg

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

C02049522/01 · Medicament · Concedì · Protecziun dals 09-08-2027 fin ils 25-06-2030

Admissiun 65332 (Swissmedic, 26-06-2015)

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

17-03-2021
Stritgà, taxa betg pajada
Published in Swissreg on 17.03.2021
22-08-2015
Represchentant inscrit
Representative
Kirker & Cie S.A., 122, rue de Genève, Case postale 90, 1226 Geneve-Thônex
Published in Swissreg on 22.08.2015
22-08-2015
Curregì
Owner
Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543-4000, USA → Bristol-Myers Squibb Holdings Ireland, Hinterbergstrasse 16, 6312 Steinhausen
Published in Swissreg on 22.08.2015
11-06-2014
Represchentant inscrit
Representative
Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich
Published in Swissreg on 11.06.2014
14-05-2014
Concedì
Published in Swissreg on 14.05.2014

Hinterbergstrasse 16, 6312 Steinhausen

Kirker & Cie S.A.

122, rue de Genève Case postale 90, 1226 Geneve-Thônex